Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Whole-exome sequencing identifies novel MPL and JAK2 mutations in triple-negative myeloproliferative neoplasms
Jelena D. Milosevic Feenstra, Harini Nivarthi, Heinz Gisslinger, et al.
Blood (2015) Vol. 127, Iss. 3, pp. 325-332
Open Access | Times Cited: 255

Showing 1-25 of 255 citing articles:

The 2016 WHO classification and diagnostic criteria for myeloproliferative neoplasms: document summary and in-depth discussion
Tiziano Barbui, Jürgen Thiele, Heinz Gisslinger, et al.
Blood Cancer Journal (2018) Vol. 8, Iss. 2
Open Access | Times Cited: 543
Genetic basis and molecular pathophysiology of classical myeloproliferative neoplasms
William Vainchenker, Róbert Královics
Blood (2016) Vol. 129, Iss. 6, pp. 667-679
Open Access | Times Cited: 531
Classification and Personalized Prognosis in Myeloproliferative Neoplasms
Jacob Grinfeld, Jyoti Nangalia, E. Joanna Baxter, et al.
New England Journal of Medicine (2018) Vol. 379, Iss. 15, pp. 1416-1430
Open Access | Times Cited: 528
Myeloproliferative Neoplasms
Jerry L. Spivak
New England Journal of Medicine (2017) Vol. 376, Iss. 22, pp. 2168-2181
Closed Access | Times Cited: 335
Differential clinical effects of different mutation subtypes in CALR-mutant myeloproliferative neoplasms
Daniela Pietra, Elisa Rumi, Virginia Valeria Ferretti, et al.
Leukemia (2015) Vol. 30, Iss. 2, pp. 431-438
Open Access | Times Cited: 249
Diagnosis, risk stratification, and response evaluation in classical myeloproliferative neoplasms
Elisa Rumi, Mario Cazzola
Blood (2016) Vol. 129, Iss. 6, pp. 680-692
Open Access | Times Cited: 226
Targeted deep sequencing in primary myelofibrosis
Ayalew Tefferi, Terra L. Lasho, Christy Finke, et al.
Blood Advances (2016) Vol. 1, Iss. 2, pp. 105-111
Open Access | Times Cited: 201
Genomic profiling for clinical decision making in myeloid neoplasms and acute leukemia
Eric J. Duncavage, Adam Bagg, Robert P. Hasserjian, et al.
Blood (2022) Vol. 140, Iss. 21, pp. 2228-2247
Open Access | Times Cited: 143
Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Aaron T. Gerds, Jason Gotlib, Haris Ali, et al.
Journal of the National Comprehensive Cancer Network (2022) Vol. 20, Iss. 9, pp. 1033-1062
Open Access | Times Cited: 82
Genetic basis and molecular profiling in myeloproliferative neoplasms
Damien Luque Paz, Róbert Královics, Radek C. Skoda
Blood (2022) Vol. 141, Iss. 16, pp. 1909-1921
Open Access | Times Cited: 82
Essential Thrombocythemia
Ayalew Tefferi, Naseema Gangat, Giuseppe Gaetano Loscocco, et al.
JAMA (2025)
Closed Access | Times Cited: 2
Presence of atypical thrombopoietin receptor (MPL) mutations in triple-negative essential thrombocythemia patients
Xénia Cabagnols, Fabrizia Favale, Florence Pasquier, et al.
Blood (2015) Vol. 127, Iss. 3, pp. 333-342
Open Access | Times Cited: 174
Myeloproliferative neoplasms: A decade of discoveries and treatment advances
Ayalew Tefferi
American Journal of Hematology (2015) Vol. 91, Iss. 1, pp. 50-58
Open Access | Times Cited: 164
Myeloproliferative neoplasm stem cells
Adam J. Mead, Ann Mullally
Blood (2017) Vol. 129, Iss. 12, pp. 1607-1616
Open Access | Times Cited: 158
Myeloproliferative neoplasms and inflammation: whether to target the malignant clone or the inflammatory process or both
Steffen Koschmieder, Tariq I. Mughal, Hans Carl Hasselbalch, et al.
Leukemia (2016) Vol. 30, Iss. 5, pp. 1018-1024
Open Access | Times Cited: 146
Myeloproliferative neoplasms: from origins to outcomes
Jyoti Nangalia, Anthony R. Green
Blood (2017) Vol. 130, Iss. 23, pp. 2475-2483
Open Access | Times Cited: 127
The 2016 revision of WHO classification of myeloproliferative neoplasms: Clinical and molecular advances
Tiziano Barbui, J. Thiele, Heinz Gisslinger, et al.
Blood Reviews (2016) Vol. 30, Iss. 6, pp. 453-459
Closed Access | Times Cited: 110
Driver mutations and prognosis in primary myelofibrosis: Mayo‐Careggi MPN alliance study of 1,095 patients
Ayalew Tefferi, Maura Nicolosi, Mythri Mudireddy, et al.
American Journal of Hematology (2017) Vol. 93, Iss. 3, pp. 348-355
Open Access | Times Cited: 108
Molecular determinants of pathogenesis and clinical phenotype in myeloproliferative neoplasms
Jacob Grinfeld, Jyoti Nangalia, Anthony R. Green
Haematologica (2016) Vol. 102, Iss. 1, pp. 7-17
Open Access | Times Cited: 90
SWI/SNF complexes in hematological malignancies: biological implications and therapeutic opportunities
Álvaro Andrades, Paola Peinado, Juan Carlos Álvarez-Pérez, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 36
Cytokine control of megakaryopoiesis
Kira Behrens, Warren S. Alexander
Growth Factors (2018) Vol. 36, Iss. 3-4, pp. 89-103
Closed Access | Times Cited: 77
How I treat essential thrombocythemia
Elisa Rumi, Mario Cazzola
Blood (2016) Vol. 128, Iss. 20, pp. 2403-2414
Open Access | Times Cited: 73
Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology
Ruben A. Mesa, Catriona Jamieson, Ravi Bhatia, et al.
Journal of the National Comprehensive Cancer Network (2016) Vol. 14, Iss. 12, pp. 1572-1611
Open Access | Times Cited: 71
Epidemiology of the classical myeloproliferative neoplasms: The four corners of an expansive and complex map
Rory M. Shallis, Rong Wang, Amy J. Davidoff, et al.
Blood Reviews (2020) Vol. 42, pp. 100706-100706
Closed Access | Times Cited: 70
Mutational landscape of the transcriptome offers putative targets for immunotherapy of myeloproliferative neoplasms
Fiorella Schischlik, Roland Jäger, Felix Rosebrock, et al.
Blood (2019) Vol. 134, Iss. 2, pp. 199-210
Open Access | Times Cited: 66
Page 1 - Next Page

Scroll to top